Literature DB >> 20045747

Surgical management of neurocysticercosis.

Vedantam Rajshekhar1.   

Abstract

Neurocysticercosis (NCC) is caused by the larval form of the pork tapeworm Taenia solium and is the commonest parasitic infestation of the central nervous system. NCC is usually managed medically but in some instances surgery is required. Magnetic resonance imaging (MRI) and computed tomography (CT) are often able to provide the diagnosis of NCC in most patients with intraventricular and parenchymal cysts but in patients with hydrocephalus without any cysts, the diagnosis is confirmed by the presence of cysticercal antibodies in the serum. Surgery is usually recommended for intraventricular cysts, hydrocephalus, large cisternal cysts, large parenchymal cysts and when the diagnosis is not certain on imaging studies. For intraventricular cysts, endoscopic surgery is the procedure of choice as it is minimally invasive. For incompletely excised cysts and cysts or granulomas in locations such as the spinal cord, medical treatment with steroids and albendazole is recommended. Hydrocephalus is treated with a ventriculo-peritoneal shunt but shunts in these patients suffer from frequent obstructions and require multiple revisions. The outcome for patients with intraventricular and parenchymal cysts is usually good but for those with hydrocephalus associated with cisternal or racemose cysts and with cysticercotic meningitis, the mortality is high. Copyright 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20045747     DOI: 10.1016/j.ijsu.2009.12.006

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  28 in total

1.  Asymptomatic Giant Intraventricular Cysticercosis: A Case Report.

Authors:  Ornusa Teerasukjinda; Suwarat Wongjittraporn; Chawat Tongma; Heath Chung
Journal:  Hawaii J Med Public Health       Date:  2016-07

Review 2.  Diagnosis and treatment of neurocysticercosis.

Authors:  Theodore E Nash; Hector H Garcia
Journal:  Nat Rev Neurol       Date:  2011-09-13       Impact factor: 42.937

Review 3.  Clinical symptoms, diagnosis, and treatment of neurocysticercosis.

Authors:  Hector H Garcia; Theodore E Nash; Oscar H Del Brutto
Journal:  Lancet Neurol       Date:  2014-11-10       Impact factor: 44.182

Review 4.  Current status and future perspectives on the medical treatment of neurocysticercosis.

Authors:  Isidro Gonzales; Hector H Garcia
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

5.  Microsurgical Treatment of Epilepsy with Parenchymal Neurocysticercosis.

Authors:  Yu-Tang Tan; Suo-Jun Zhang; Kai Shu; Ting Lei; Hong-Quan Niu
Journal:  Curr Med Sci       Date:  2019-12-16

Review 6.  Conservative management of neurocysticercosis in a patient with hematopoietic stem cell transplantation: a case report and review.

Authors:  S Purvey; K Lu; S K Mukkamalla; P Anandi; B Dumitriu; S Kranick; D A Hammoud; E O'Connell; A L Oh; J Barrett; S Mahanty; M Battiwalla
Journal:  Transpl Infect Dis       Date:  2015-06-01       Impact factor: 2.228

Review 7.  Clinical manifestations, diagnosis, and treatment of neurocysticercosis.

Authors:  Julio Sotelo
Journal:  Curr Neurol Neurosci Rep       Date:  2011-12       Impact factor: 5.081

8.  Neurocysticercosis: an update.

Authors:  Christina M Coyle
Journal:  Curr Infect Dis Rep       Date:  2014-11       Impact factor: 3.725

Review 9.  Pediatric neurocysticercosis.

Authors:  Ricardo Santos de Oliveira; Dinark Conceição Viana; Benedicto Oscar Colli; Vedantam Rajshekhar; José Francisco Manganelli Salomão
Journal:  Childs Nerv Syst       Date:  2018-07-09       Impact factor: 1.475

Review 10.  Taenia solium Cysticercosis and Its Impact in Neurological Disease.

Authors:  Hector H Garcia; Armando E Gonzalez; Robert H Gilman
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.